Literature DB >> 29713948

Association Study of ANRIL Genetic Variants and Multiple Sclerosis.

Maryam Rezazadeh1, Jalal Gharesouran1,2, Mohsen Moradi1, Rezvan Noroozi2,3, Mir Davood Omrani2,4, Mohammad Taheri5,6, Soudeh Ghafouri-Fard7.   

Abstract

Multiple sclerosis (MS) is an autoimmune disorder of central nervous system with several genetic and environmental risk factors. Genes with regulatory roles on immune system have been implicated in its pathogenesis. Recently, long non-coding RNAs (lncRNAs) have been demonstrated to control some aspects of immune response. Among them is antisense non-coding RNA in the INK4 locus (ANRIL) whose involvement in NF-κB signaling pathway has been highlighted. In the current study, we evaluated the association between rs1333045, rs4977574, rs1333048, and rs10757278 variants of ANRIL and MS risk in a population of 410 Iranian MS patients and 410 healthy subjects. There was no significant difference in allele and genotype frequencies between MS patients and healthy subjects. However, haplotype analysis (rs1333045, rs1333048, rs4977574, and rs10757278 respectively) demonstrated protective effect of CCGG and TAAA haplotypes against MS (P values of 0.043 and 0.0026 respectively). In addition, TAGG and CCGA haplotypes were significantly associated with MS risk in the studied population (P values of 0.0065 and 0.024 respectively). The present study reveals a possible role for ANRIL in the pathogenesis of MS.

Entities:  

Keywords:  ANRIL; Association study; Multiple sclerosis; lncRNA

Mesh:

Substances:

Year:  2018        PMID: 29713948     DOI: 10.1007/s12031-018-1069-3

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  28 in total

1.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

2.  CDKN2BAS is associated with periodontitis in different European populations and is activated by bacterial infection.

Authors:  Arne S Schaefer; Gesa M Richter; Henrik Dommisch; Markus Reinartz; Michael Nothnagel; Barbara Noack; Marja L Laine; Mathias Folwaczny; Birte Groessner-Schreiber; Bruno G Loos; Søren Jepsen; Stefan Schreiber
Journal:  J Med Genet       Date:  2010-10-26       Impact factor: 6.318

3.  Association of ANRIL gene polymorphisms with prostate cancer and benign prostatic hyperplasia in an Iranian population.

Authors:  Mohammad Taheri; Farkhondeh Pouresmaeili; Mir Davood Omrani; Mohsen Habibi; Shaghayegh Sarrafzadeh; Rezvan Noroozi; Azadeh Rakhshan; Arezou Sayad; Soudeh Ghafouri-Fard
Journal:  Biomark Med       Date:  2017-05       Impact factor: 2.851

4.  Phospholipase D1 expression analysis in relapsing-remitting multiple sclerosis patients.

Authors:  Mohammad Mahdi Eftekharian; Tahereh Azimi; Soudeh Ghafouri-Fard; Arezou Sayad; Mir Davood Omrani; Shaghayegh Sarrafzadeh; Roghayeh Abbasalipourkabir; Mehrdokht Mazdeh; Mohammad Taheri
Journal:  Neurol Sci       Date:  2017-02-22       Impact factor: 3.307

5.  Myxovirus resistance protein A (MxA) polymorphism is associated with IFNβ response in Iranian multiple sclerosis patients.

Authors:  Arezou Sayad; Soudeh Ghafouri-Fard; Mir Davood Omrani; Rezvan Noroozi; Mohammad Taheri
Journal:  Neurol Sci       Date:  2017-04-06       Impact factor: 3.307

6.  Determination of cytokine levels in multiple sclerosis patients and their relevance with patients' response to Cinnovex.

Authors:  Mohammad Taheri; Soudeh Ghafouri-Fard; Ghasem Solgi; Arezou Sayad; Mehrdokht Mazdeh; Mir Davood Omrani
Journal:  Cytokine       Date:  2017-04-09       Impact factor: 3.861

7.  Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression.

Authors:  Michael S Cunnington; Mauro Santibanez Koref; Bongani M Mayosi; John Burn; Bernard Keavney
Journal:  PLoS Genet       Date:  2010-04-08       Impact factor: 5.917

8.  The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation.

Authors:  Pin Wang; Yiquan Xue; Yanmei Han; Li Lin; Cong Wu; Sheng Xu; Zhengping Jiang; Junfang Xu; Qiuyan Liu; Xuetao Cao
Journal:  Science       Date:  2014-04-18       Impact factor: 47.728

Review 9.  ANRIL: molecular mechanisms and implications in human health.

Authors:  Ada Congrains; Kei Kamide; Mitsuru Ohishi; Hiromi Rakugi
Journal:  Int J Mol Sci       Date:  2013-01-10       Impact factor: 5.923

Review 10.  The Role of Long Non-Coding RNAs in Ovarian Cancer.

Authors:  Elahe Nikpayam; Behnoosh Tasharrofi; Shaghayegh Sarrafzadeh; Soudeh Ghafouri-Fard
Journal:  Iran Biomed J       Date:  2016-09-24
View more
  9 in total

1.  Elevated circulating lnc-ANRIL/miR-125a axis level predicts higher risk, more severe disease condition, and worse prognosis of sepsis.

Authors:  Feng Gui; Huan Peng; Yijue Liu
Journal:  J Clin Lab Anal       Date:  2019-05-21       Impact factor: 2.352

2.  ANRIL Variants Are Associated with Risk of Neuropsychiatric Conditions.

Authors:  Amir Namvar; Mir Salar Kahaei; Hamid Fallah; Fwad Nicknafs; Soudeh Ghafouri-Fard; Mohammad Taheri
Journal:  J Mol Neurosci       Date:  2019-11-26       Impact factor: 3.444

3.  Long non-coding RNA ANRIL interacts with microRNA-34a and microRNA-125a, and they all correlate with disease risk and severity of Parkinson's disease.

Authors:  Peng Yang; Guiqing Lin; Minli Wang; Xuewei Chen; Jian Huang
Journal:  J Clin Lab Anal       Date:  2021-12-17       Impact factor: 2.352

4.  Dysregulation of long noncoding RNA MEG3 and NLRC5 expressions in patients with relapsing-remitting multiple sclerosis: is there any correlation?

Authors:  Shahram Torkamandi; Shima Bahrami; Tahereh Ghorashi; Mohammad Dehani; Hadi Bayat; Seyyed Mohamad Hoseini; Somaye Rezaei; Mohsen Soosanabadi
Journal:  Genes Immun       Date:  2021-11-15       Impact factor: 2.676

5.  Long Non-coding RNAs Genes Polymorphisms and Their Expression Levels in Patients With Rheumatoid Arthritis.

Authors:  Tian-Ping Zhang; Bang-Qiang Zhu; Sha-Sha Tao; Yin-Guang Fan; Xiao-Mei Li; Hai-Feng Pan; Dong-Qing Ye
Journal:  Front Immunol       Date:  2019-10-31       Impact factor: 7.561

Review 6.  What do we know about the role of lncRNAs in multiple sclerosis?

Authors:  Viviana Nociti; Massimo Santoro
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

Review 7.  ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease.

Authors:  Yahui Kong; Chih-Heng Hsieh; Laura C Alonso
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-24       Impact factor: 5.555

8.  Integrating the Ribonucleic Acid Sequencing Data From Various Studies for Exploring the Multiple Sclerosis-Related Long Noncoding Ribonucleic Acids and Their Functions.

Authors:  Zhijie Han; Jiao Hua; Weiwei Xue; Feng Zhu
Journal:  Front Genet       Date:  2019-11-12       Impact factor: 4.599

Review 9.  Long Non-Coding RNAs, Novel Offenders or Guardians in Multiple Sclerosis: A Scoping Review.

Authors:  Abbas Jalaiei; Mohammad Reza Asadi; Hani Sabaie; Hossein Dehghani; Jalal Gharesouran; Bashdar Mahmud Hussen; Mohammad Taheri; Soudeh Ghafouri-Fard; Maryam Rezazadeh
Journal:  Front Immunol       Date:  2021-12-07       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.